Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the ras-ERK pathway when compared with blood eosinophils

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7125-7133

  Bates, Mary Ellen ^a   Sedgwick, Julie B ^a   Zhu, Yiming ^a   Liu, Lin Ying ^a   Heuser, Rose G ^a   Jarjour, Nizar N ^a   Kita, Hirohito ^b   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; FIBRONECTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTOXIN; RANTES; RAS PROTEIN; THROMBOCYTE ACTIVATING FACTOR; CHEMOTACTIC FACTOR; EOSINOPHIL PROTEIN X; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LUNG LAVAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADOLESCENT; BIOSYNTHESIS; CELL ADHESION; COMPARATIVE STUDY; CYTOLOGY; IMMUNOBLOTTING; IMMUNOLOGY; LUNG; METABOLISM; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS;

ADOLESCENT; ADULT; CELL ADHESION; CELL DEGRANULATION; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; ENZYME ACTIVATION; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; LUNG; MIDDLE AGED; RAS PROTEINS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 77953641765     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900634     Document Type: Article

References (64)

1. Holgate, S. T. 2008. Pathogenesis of asthma. Clin. Exp. Allergy 38: 872-897.
2. Sedgwick, J. B., W. J. Calhoun, R. F. Vrtis, M. E. Bates, P. K. McAllister, and W. W. Busse. 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149: 3710-3718.
3. Liu, L. Y., J. B. Sedgwick, M. E. Bates, R. F. Vrtis, J. E. Gern, H. Kita, N. N. Jarjour, W. W. Busse, and E. A. Kelly. 2002. Decreased expression of membrane IL-5 receptor alpha on human eosinophils. I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J. Immunol. 169: 6452-6458.
4. Bates, M. E., L. Y. Liu, S. Esnault, B. A. Stout, E. Fonkem, V. Kung, J. B. Sedgwick, E. A. Kelly, D. M. Bates, J. S. Malter, et al. 2004. Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am. J. Respir. Cell Mol. Biol. 30: 736-743.
5. Luijk, B., C. A. Lindemans, D. Kanters, R. van der Heijde, P. Bertics, J. W. J. Lammers, M. E. Bates, and L. Koenderman. 2005. Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J. Allergy Clin. Immunol. 115: 997-1003.
6. Brooks, A. M., M. E. Bates, R. F. Vrtis, N. N. Jarjour, P. J. Bertics, and J. B. Sedgwick. 2006. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am. J. Respir. Cell Mol. Biol. 35: 503-511.
7. Sedgwick, J. B., S. F. Quan, W. J. Calhoun, and W. W. Busse. 1995. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J. Allergy Clin. Immunol. 96: 375-385.
8. Ko, F. W., C. Y. Lau, T. F. Leung, G. W. Wong, C. W. Lam, C. K. Lai, and D. S. Hui. 2006. Exhaled breath condensate levels of eotaxin and macrophag-ederived chemokine in stable adult asthma patients. Clin. Exp. Allergy 36: 44-51.
9. Kivity, S., A. Argaman, A. Onn, Y. Shwartz, A. Man, J. Greif, and E. Fireman. 2000. Eosinophil influx into the airways in patients with exercise-induced asthma. Respir. Med. 94: 1200-1205.
10. Calabrese, C., M. Triggiani, G. Marone, and G. Mazzarella. 2000. Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy 55(Suppl. 61): 27-30. (Pubitemid 30430375)
11. Levy, B. D., G. T. De Sanctis, P. R. Devchand, E. Kim, K. Ackerman, B. A. Schmidt, W. Szczeklik, J. M. Drazen, and C. N. Serhan. 2002. Multipronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat. Med. 8: 1018-1023.
12. Le, Y., Y. Zhou, H. Tao, and J. M. Wang. 2004. Formylpeptide receptors and their potential roles in inflammatory airway diseases. Clin. Exp. Allergy Rev. 4: 155-161.
13. Barthel, S. R., N. N. Jarjour, D. F. Mosher, and M. W. Johansson. 2006. Dissection of the hyperadhesive phenotype of airway eosinophils in asthma. Am. J. Respir. Cell Mol. Biol. 35: 378-386.
14. Ulfman, L. H., J. Alblas, C. W. van Aalst, J. J. Zwaginga, and L. Koenderman. 2005. Differences in potency of CXC chemokine ligand 8-, CC chemokine ligand 11-, and C5a-induced modulation of integrin function on human eosinophils. J. Immunol. 175: 6092-6099.
15. Boehme, S. A., S. K. Sullivan, P. D. Crowe, M. Santos, P. J. Conlon, P. Sriramarao, and K. B. Bacon. 1999. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol. 163: 1611-1618.
16. Broide, D., and P. Sriramarao. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179: 163-172.
17. Fujisawa, T., Y. Kato, H. Nagase, J. Atsuta, A. Terada, K. Iguchi, H. Kamiya, Y. Morita, M. Kitaura, H. Kawasaki, et al. 2000. Chemokines induce eosinophil degranulation through CCR-3. J. Allergy Clin. Immunol. 106: 507-513.
18. Kampen, G. T., S. Stafford, T. Adachi, T. Jinquan, S. Quan, J. A. Grant, P. S. Skov, L. K. Poulsen, and R. Alam. 2000. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95: 1911-1917.
19. Shin, M. H., Y. A. Lee, Y. S. Bae, H. Kita, Y. Kim, and S. H. Ryu. 2005. The synthetic chemoattractant peptide WKYMVm induces superoxide production by human eosinophils via the phosphoinositide 3-kinase-mediated activation of ERK1/2. Int. Arch. Allergy Immunol. 137(Suppl. 1): 21-26.
20. Mishra, R. K., J. E. Scaife, Z. Harb, B. C. Gray, R. Djukanovic, and G. Dent. 2005. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 60: 1204-1207.
21. Bates, M. E., V. L. Green, and P. J. Bertics. 2000. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C4 biosynthesis. J. Biol. Chem. 275: 10968-10975.
22. Miyamasu, M., K. Hirai, Y. Takahashi, M. Iida, M. Yamaguchi, T. Koshino, T. Takaishi, Y. Morita, K. Ohta, T. Kasahara, et al. 1995. Chemotactic agonists induce cytokine generation in eosinophils. J. Immunol. 154: 1339-1349.
23. Nakajima, T., H. Yamada, M. Iikura, M. Miyamasu, S. Izumi, H. Shida, K. Ohta, T. Imai, O. Yoshie, M. Mochizuki, et al. 1998. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434: 226-230. (Pubitemid 29052230)
24. Rossi, A. G., C. Haslett, N. Hirani, A. P. Greening, I. Rahman, C. N. Metz, R. Bucala, and S. C. Donnelly. 1998. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J. Clin. Invest. 101: 2869-2874.
25. Coffer, P. J., and L. Koenderman. 1997. Granulocyte signal transduction and priming: cause without effect? Immunol. Lett. 57: 27-31.
26. Koenderman, L., A. T. Tool, D. Roos, and A. J. Verhoeven. 1990. Priming of the respiratory burst in human eosinophils is accompanied by changes in signal transduction. J. Immunol. 145: 3883-3888.
27. 2+-independent route. J. Immunol. 142: 623-628.
28. Schweizer, R. C., B. A. Welmers, J. A. Raaijmakers, P. Zanen, J. W. Lammers, and L. Koenderman. 1994. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83: 3697-3704.
29. Takafuji, S., S. C. Bischoff, A. L. De Weck, and C. A. Dahinden. 1991. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J. Immunol. 147: 3855-3861.
30. Warringa, R. A., R. C. Schweizer, T. Maikoe, P. H. Kuijper, P. L. Bruijnzeel, and L. Koendermann. 1992. Modulation of eosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell Mol. Biol. 7: 631-636.
31. Coëffier, E., D. Joseph, and B. B. Vargaftig. 1994. Modulation of the enhanced migration of eosinophils from the airways of sensitized guinea pigs: role of IL-5. Ann. NY Acad. Sci. 725: 274-281.
32. Fernvik, E., J. Lundahl, and G. Halldén. 2000. The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers. Inflammation 24: 73-87. (Pubitemid 30105940)
33. Hall, D. J., J. Cui, M. E. Bates, B. A. Stout, L. Koenderman, P. J. Coffer, and P. J. Bertics. 2001. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood 98: 2014-2021.
34. Nagata, M., J. B. Sedgwick, H. Kita, and W. W. Busse. 1998. Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am. J. Respir. Cell Mol. Biol. 19: 158-166.
35. Sedgwick, J. B., W. J. Calhoun, G. J. Gleich, H. Kita, J. S. Abrams, L. B. Schwartz, B. Volovitz, M. Ben-Yaakov, and W. W. Busse. 1991. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144: 1274-1281.
36. Kelly, E. A., W. W. Busse, and N. N. Jarjour. 2000. Inhaled budesonide decreases airway inflammatory response to allergen. Am. J. Respir. Crit. Care Med. 162: 883-890.
37. Meerschaert, J., E. A. Kelly, D. F. Mosher, W. W. Busse, and N. N. Jarjour. 1999. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 159: 619-625.
38. Lundahl, J., A. Moshfegh, R. Grönneberg, and G. Halldén. 1998. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL5, but not fMLP-prestimulated human peripheral blood eosinophils. Inflammation 22: 123-135. (Pubitemid 28177171)
39. Anwar, A. R., R. Moqbel, G. M. Walsh, A. B. Kay, and A. J. Wardlaw. 1993. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177: 839-843.
40. Sano, H., X. Zhu, A. Sano, E. E. Boetticher, T. Shioya, B. Jacobs, N. M. Munoz, and A. R. Leff. 2001. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of cytosolic phospholipase A2 is essential for human eosinophil adhesion to fibronectin. J. Immunol. 166: 3515-3521.
41. Shin, E. H., Y. Osada, H. Sagara, K. Takatsu, and S. Kojima. 2001. Involvement of complement and fibronectin in eosinophil-mediated damage to Nippostrongylus brasiliensis larvae. Parasite Immunol. 23: 27-37.
42. Sung, K. P., L. Yang, J. Kim, D. Ko, G. Stachnick, D. Castaneda, J. Nayar, and D. H. Broide. 2000. Eotaxin induces a sustained reduction in the functional adhesive state of very late antigen 4 for the connecting segment 1 region of fibronectin. J. Allergy Clin. Immunol. 106: 933-940.
43. Xu, X., and L. Håkansson. 2000. Regulation of the release of eosinophil cationic protein by eosinophil adhesion. Clin. Exp. Allergy 30: 794-806.
44. Meerschaert, J., R. F. Vrtis, Y. Shikama, J. B. Sedgwick, W. W. Busse, and D. F. Mosher. 1999. Engagement of alpha4beta7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro. J. Immunol. 163: 6217-6227.
45. Myou, S., X. Zhu, E. Boetticher, S. Myo, A. Meliton, A. Lambertino, N. M. Munoz, and A. R. Leff. 2002. Blockade of focal clustering and active conformation in beta 2-integrin-mediated adhesion of eosinophils to intercellular adhesion molecule-1 caused by transduction of HIV TAT-dominant negative Ras. J. Immunol. 169: 2670-2676.
46. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183: 2437-2448.
47. Liu, L. Y., N. N. Jarjour, W. W. Busse, and E. A. Kelly. 2003. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J. Allergy Clin. Immunol. 112: 556-562.
48. Nagase, H., K. Kudo, S. Izumi, K. Ohta, N. Kobayashi, M. Yamaguchi, K. Matsushima, Y. Morita, K. Yamamoto, and K. Hirai. 2001. Chemokine receptor expression profile of eosinophils at inflamed tissue sites: decreased CCR3 and increased CXCR4 expression by lung eosinophils. J. Allergy Clin. Immunol. 108: 563-569.
49. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23: 541-548.
50. Bates, M. E., P. J. Bertics, and W. W. Busse. 1996. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J. Immunol. 156: 711-718.
51. Sedgwick, J. B., and W. W. Busse. 1993. Adhesion proteins on airway eosinophils in allergy and asthma. Agents Actions Suppl. 43: 163-172.
52. Horie, S., G. J. Gleich, and H. Kita. 1996. Cytokines directly induce degranulation and superoxide production from human eosinophils. J. Allergy Clin. Immunol. 98: 371-381.
53. Nagata, M., J. B. Sedgwick, M. E. Bates, H. Kita, and W. W. Busse. 1995. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J. Immunol. 155: 2194-2202.
54. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1997. Description of an in vivo model for the assessment of eosinophil chemoattractants in the mouse. Mem. Inst. Oswaldo Cruz 92(Suppl. 2): 211-214.
55. Wardlaw, A. J., G. M. Walsh, and F. A. Symon. 1996. Adhesion interactions involved in eosinophil migration through vascular endothelium. Ann. NY Acad. Sci. 796: 124-137.
56. Tachimoto, H., and B. S. Bochner. 2000. The surface phenotype of human eosinophils. Chem. Immunol. 76: 45-62.
57. Barthel, S. R., M. W. Johansson, D. M. McNamee, and D. F. Mosher. 2008. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J. Leukoc. Biol. 83: 1-12.
58. Anwar, A. R., G. M. Walsh, O. Cromwell, A. B. Kay, and A. J. Wardlaw. 1994. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology 82: 222-228.
59. Foster, A. P., P. J. McCabe, S. Sanjar, and F. M. Cunningham. 1997. Agonist-induced adherence of equine eosinophils to fibronectin. Vet. Immunol. Immunopathol. 56: 205-220.
60. Johansson, M. W., E. A. Kelly, W. W. Busse, N. N. Jarjour, and D. F. Mosher. 2008. Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge. J. Immunol. 180: 7622-7635.
61. Badewa, A. P., and A. S. Heiman. 2003. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase, and PI 3-kinase. Immunopharmacol. Immunotoxicol. 25: 145-157.
62. Svensson, L., C. Dahlgren, and C. Wennerås. 2002. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J. Leukoc. Biol. 72: 810-818.
63. Koenderman, L., S. W. Hermans, P. J. Capel, and J. G. van de Winkel. 1993. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. Blood 81: 2413-2419. (Pubitemid 23127079)
64. Bracke, M., P. J. Coffer, J. W. Lammers, and L. Koenderman. 1998. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J. Immunol. 161: 6768-6774. (Pubitemid 28562220)